Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00995072 · ClinicalTrials.gov registry record · NA
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
A NA study, sponsored by East Coast Institute for Research.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00995072 is a NA study that has completed, run by East Coast Institute for Research. The registered enrollment target is 29 participants.
The verdict
NCT00995072, a NA study, has completed, sponsored by East Coast Institute for Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Beta-blockers (BB) are an important treatment for high blood pressure and heart disease. However beta-blockers can cause sexual dysfunction (SD) and this common side effect limits successful use of this class of medications. Sexual side effects often result in drug discontinuation, compromising therapy goals. The investigators are conducting the study to determine if nebivolol, a newer beta blocker that is selective for receptors in the heart and causes vasodilation in the body causes fewer sexual side effects, or even improves sexual function, compared with metoprolol succinate.
Interventions
- DRUG nebivolol and metoprolol succinate
- DRUG metoprolol succinate and nebivolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00995072
The ClinicalTrials.gov registry entry for NCT00995072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is East Coast Institute for Research, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nebivolol and metoprolol succinate is the first listed.
NCT00995072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00995072 about?
NCT00995072 is a clinical study titled "Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function". Beta-blockers (BB) are an important treatment for high blood pressure and heart disease. However beta-blockers can cause sexual dysfunction (SD) and this common side effect limits successful use of this class of medications. Sexual side effects often result in drug discontinuation, compromising ther...
What is the current status of trial NCT00995072?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2009-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00995072?
The interventions under investigation include: nebivolol and metoprolol succinate (DRUG), metoprolol succinate and nebivolol (DRUG).
Who is sponsoring clinical trial NCT00995072?
This trial is sponsored by East Coast Institute for Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.